Grabs CTO on Physical AI and Automated Driving Why He Keeps Competitors Robots in the Office Berkshire Hathaway Returns to Skies with 26 Billion Delta Air Lines Stake Disneys The Mandalorian and Grogu Posts LowestEver Star Wars Opening Weekend at Box Office Bitcoin Slips Below 76000 Eyes Weekly Loss Amid Liquidations and Interest Rate Uncertainty Micron Stock Surges to Milestone as UBS Boosts Price Target on Strong Memory Chip Demand Costcos LongTerm Potential Could a 10000 Stake Grow Into a Million SANUWAVE Health Inc Q1 2026 Earnings Significant EPS Miss Leads to Stock Decline MarketAxess Holdings Inc MKTX Q1 2026 Earnings EPS Beat Drives Modest Share Uptick Live Oak Bancshares Inc Q1 2026 Earnings EPS Beats Estimates by 174 Amid Mixed Market Response IMMX Q1 2026 Earnings Narrowed Loss as Biotech Advances Oncology Pipeline HTB Q1 2026 Earnings EPS Surges Past Estimates with a 20 Beat PDLB Q4 2025 Earnings Significant EPS Beat Despite Modest Stock Decline Xunlei XNET Edges Lower Amid Consolidation Near 544 Bitfarms Ltd BITF Holds Steady at 198 as Crypto Mining Sector Watches Key Levels EverQuote EVER Edges Higher Consolidating Near Key Resistance Amid Sector Movements Allegro MicroSystems ALGM Surges 28 as Bulls Test Key Resistance at 4825 PIMCO Dynamic Income Strategy Fund PDX Edges Lower Amidst Consolidation US April Payrolls Jump More Than Expected Yet Report Reveals Several Economic Red Flags Eledon Pharmaceuticals Q1 2026 Earnings EPS Misses Estimates as Company Continues Clinical Pipeline Development Passage Bio Inc PASG Edges Higher Testing Key Resistance Levels Morgan Stanley Emerging Markets Debt Fund Inc MSD Holds Steady Near Resistance Amid Modest Uptick Haemonetics HAE Rises 116 as Shares Approach Resistance Level NeOnc Technologies Holdings NTHI Holds Near Support as Modest Decline Tests Key Level Greenlane Holdings GNLN Rallies 435 Testing Key Resistance Level Ares Management ARES Holds Steady Above Support Despite Marginal Gain Empery Digital Inc EMPD Stock Retreats 236 as Price Tests Key Support Zone Akari Therapeutics AKTX Plunges 126 Amid Heightened Biotech Volatility